Literature DB >> 23905086

The role of the endogenous antioxidant enzymes and malondialdehyde in essential hypertension.

Aquil Ahmad1, Usha Singhal, Mohd Mobark Hossain, Najmul Islam, Imran Rizvi.   

Abstract

CONTEXT: Oxidative Stress is caused by an imbalance between the production of reactive oxygen species and a biological system's ability to readily detoxify the reactive intermediates. AIMS: 1. To compare the levels of Malondialdehyde (MDA), in hypertensive and normotensive subjects. 2. To compare the levels of the antioxidant enzymes, namely, Catalase, Glutathione peroxidase (GPX) and Superoxide Dismutase (SOD) in hypertensive and normotensive subjects. 3. To determine the correlation between the MDA levels and the mean arterial pressure (MAP) among hypertensive subjects. 4. To determine the correlation between the antioxidant enzyme levels and MAP among the hypertensive subjects and to evaluate the effect of 6 months of antihypertensive therapy with a tight blood pressure control on the MDA levels. Materials and Methods : In this cross sectional study, 25 normotensive and 40 hypertensive subjects were recruited. The hypertensive subjects were further subdivided into three subgroups: Prehypertensives, Stage I hypertensives and Stage II hypertensives. All the subjects underwent a blood pressure measurement and the markers of oxidative stress in their sera were estimated. The subjects of Stage I hypertension and Stage II hypertension were given antihypertensive treatment for 6 months and their blood pressures were tightly regulated and brought to the normotensive state. After 6 months, the estimations of the markers of oxidative stress were done again.
RESULTS: The MDA levels were significantly increased in the stage I and stage II hypertension groups as compared to those of the control group (p<0.05). The antioxidant enzymes (SOD, Catalase and GPX) were significantly decreased (p<0.05) in the prehypertension and in the stage I and stage II hypertension groups as compared to those in the control group. There was a significant increase in the levels of the antioxidant enzymes after 6 months of a tight regulation and bringing of the blood pressure to the normotensive state by giving antihypertensive therapy.
CONCLUSION: On comparison of the present study with other studies in which the use of antioxidants were found to be ineffective in the blood pressure reduction, it can be concluded that oxidative stress is an effect rather than a cause of essential hypertension.

Entities:  

Keywords:  Catalase; Essential hypertension; Glutathione peroxidase; Oxidative Stress; Superoxide Dismutase Antihypertensive therapy

Year:  2013        PMID: 23905086      PMCID: PMC3708256          DOI: 10.7860/JCDR/2013/5829.3091

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  19 in total

1.  Lack of long-term effect of vitamin C supplementation on blood pressure.

Authors:  Mi Kyung Kim; Satoshi Sasaki; Shizuka Sasazuki; Shunji Okubo; Masato Hayashi; Shoichiro Tsugane
Journal:  Hypertension       Date:  2002-12       Impact factor: 10.190

2.  Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study.

Authors:  Bryan Williams; Peter S Lacy; Simon M Thom; Kennedy Cruickshank; Alice Stanton; David Collier; Alun D Hughes; H Thurston; Michael O'Rourke
Journal:  Circulation       Date:  2006-02-13       Impact factor: 29.690

3.  Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein).

Authors:  J M McCord; I Fridovich
Journal:  J Biol Chem       Date:  1969-11-25       Impact factor: 5.157

4.  Catalase in vitro.

Authors:  H Aebi
Journal:  Methods Enzymol       Date:  1984       Impact factor: 1.600

5.  Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase.

Authors:  D E Paglia; W N Valentine
Journal:  J Lab Clin Med       Date:  1967-07

6.  Enhanced superoxide anion formation in vascular tissues from spontaneously hypertensive and desoxycorticosterone acetate-salt hypertensive rats.

Authors:  R Wu; E Millette; L Wu; J de Champlain
Journal:  J Hypertens       Date:  2001-04       Impact factor: 4.844

7.  Antioxidant-rich diet relieves hypertension and reduces renal immune infiltration in spontaneously hypertensive rats.

Authors:  Bernardo Rodriguez-Iturbe; Chang-De Zhan; Yasmir Quiroz; Ram K Sindhu; Nosratola D Vaziri
Journal:  Hypertension       Date:  2003-02       Impact factor: 10.190

8.  MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial.

Authors: 
Journal:  Lancet       Date:  2002-07-06       Impact factor: 79.321

Review 9.  Reactive oxygen species in the vasculature: molecular and cellular mechanisms.

Authors:  Yoshihiro Taniyama; Kathy K Griendling
Journal:  Hypertension       Date:  2003-10-27       Impact factor: 10.190

Review 10.  Regulation of superoxide anion production by NADPH oxidase in monocytes/macrophages: contributions to atherosclerosis.

Authors:  Martha K Cathcart
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-10-02       Impact factor: 8.311

View more
  18 in total

1.  Serum Malondialdehyde Levels in Hypertensive Patients: A Non-invasive Marker of Oxidative Stress. A Systematic Review and Meta-analysis.

Authors:  Marco Zuin; Elenonora Capatti; Claudio Borghi; Giovanni Zuliani
Journal:  High Blood Press Cardiovasc Prev       Date:  2022-03-28

2.  Biomarkers of lipid peroxidation related to hypertension in aging.

Authors:  Hakan Yavuzer; Serap Yavuzer; Mahir Cengiz; Hayriye Erman; Alper Doventas; Huriye Balci; Deniz Suna Erdincler; Hafize Uzun
Journal:  Hypertens Res       Date:  2016-01-14       Impact factor: 3.872

3.  Biomarkers of antioxidant status and lipid peroxidation in elderly patients with hypertension.

Authors:  Hanna Pawluk; Robert Pawluk; Joanna Robaczewska; Kornelia Kędziora-Kornatowska; Józef Kędziora
Journal:  Redox Rep       Date:  2017-09-05       Impact factor: 4.412

4.  Selected spices and their combination modulate hypercholesterolemia-induced oxidative stress in experimental rats.

Authors:  Gloria A Otunola; Oyelola B Oloyede; Adenike T Oladiji; Anthony J Afolayan
Journal:  Biol Res       Date:  2014-03-26       Impact factor: 5.612

5.  Correlation of zinc with oxidative stress biomarkers.

Authors:  María Morales-Suárez-Varela; Agustín Llopis-González; Verónica González-Albert; Raúl López-Izquierdo; Isabel González-Manzano; Javier Cháves; Vicente Huerta-Biosca; Juan C Martin-Escudero
Journal:  Int J Environ Res Public Health       Date:  2015-03-12       Impact factor: 3.390

6.  Lymphocyte DNA damage and plasma antioxidant status in Korean subclinical hypertensive patients by glutathione S-transferase polymorphism.

Authors:  Jeong-Hwa Han; Hye-Jin Lee; Hee Jeong Choi; Kyung Eun Yun; Myung-Hee Kang
Journal:  Nutr Res Pract       Date:  2017-04-05       Impact factor: 1.926

Review 7.  Antioxidants and Cardiovascular Risk Factors.

Authors:  Daniela Pellegrino
Journal:  Diseases       Date:  2016-02-17

8.  Beneficial Effects of Different Flavonoids on Vascular and Renal Function in L-NAME Hypertensive Rats.

Authors:  M Dolores Paredes; Paola Romecín; Noemí M Atucha; Francisco O'Valle; Julián Castillo; M Clara Ortiz; Joaquín García-Estañ
Journal:  Nutrients       Date:  2018-04-13       Impact factor: 5.717

9.  Analysis of oxidative stress enzymes and structural and functional proteins on human aortic tissue from different aortopathies.

Authors:  María Elena Soto; Elizabeth Soria-Castro; Verónica Guarner Lans; Eleazar Muruato Ontiveros; Benjamín Iván Hernández Mejía; Humberto Jorge Martínez Hernandez; Rodolfo Barragán García; Valentín Herrera; Israel Pérez-Torres
Journal:  Oxid Med Cell Longev       Date:  2014-07-01       Impact factor: 6.543

10.  Impaired Oxidative Status Is Strongly Associated with Cardiovascular Risk Factors.

Authors:  E Brunelli; D La Russa; D Pellegrino
Journal:  Oxid Med Cell Longev       Date:  2017-12-12       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.